Hua X. Zhu

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 624 publications

First-in-Class CD146-Targeting Peptide Probes for Noninvasive PET Imaging of Melanoma.

First-in-Class CD146-Targeting Peptide Probes for Noninvasive PET Imaging of Melanoma.

Journal: Molecular pharmaceutics
Published: July 07, 2026

Corrigendum to "PET radiotracers targeting MDM2 protein interaction: From preclinical validation to first-in-human studies" [Pharmacol. Res. (2026) 230 108314].

Corrigendum to "PET radiotracers targeting MDM2 protein interaction: From preclinical validation to first-in-human studies" [Pharmacol. Res. (2026) 230 108314].

Journal: Pharmacological research
Published: June 25, 2026

Construction of a 89Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors.

Construction of a 89Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors.

Journal: Molecular pharmaceutics
Published: May 12, 2026

Optimization of Chelator Conjugation to PD-1/VEGF Bispecific Antibody for 89Zr-ImmunoPET Imaging.

Optimization of Chelator Conjugation to PD-1/VEGF Bispecific Antibody for 89Zr-ImmunoPET Imaging.

Journal: Journal of medicinal chemistry
Published: April 24, 2026

Cloud-based ligand-guided virtual screening with deep-learning-enhanced docking identifies a micromolar CXCR4 antagonist.

Cloud-based ligand-guided virtual screening with deep-learning-enhanced docking identifies a micromolar CXCR4 antagonist.

Journal: Molecular diversity
Published: April 12, 2026

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.

Journal: Cell stem cell
Published: April 10, 2026

Advances in Delta-like Ligand 3-Targeted Diagnosis and Treatment.

Advances in Delta-like Ligand 3-Targeted Diagnosis and Treatment.

Journal: Molecular pharmaceutics
Published: April 10, 2026

Early diabetes-like phenotypes in germ-free mice induced by gut microbiota from patients with type 2 diabetes.

Early diabetes-like phenotypes in germ-free mice induced by gut microbiota from patients with type 2 diabetes.

Journal: Animal models and experimental medicine
Published: April 10, 2026

Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine.

Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine.

Journal: Molecular pharmaceutics
Published: March 31, 2026

Tislelizumab combined with gemcitabine plus cisplatin for muscle-invasive upper tract urothelial carcinoma: A retrospective single-center cohort analysis.

Tislelizumab combined with gemcitabine plus cisplatin for muscle-invasive upper tract urothelial carcinoma: A retrospective single-center cohort analysis.

Journal: The Journal of international medical research
Published: March 30, 2026

Serum high-density lipoprotein partially mediates the inverted L-shaped association between estimated glucose disposal rate and risk of kidney stones: A cross-sectional study from National Health and Nutrition Examination Survey.

Serum high-density lipoprotein partially mediates the inverted L-shaped association between estimated glucose disposal rate and risk of kidney stones: A cross-sectional study from National Health and Nutrition Examination Survey.

Journal: The Journal of international medical research
Published: March 30, 2026

Hypertension-associated gut dysbiosis drives target organ damage through impaired polyunsaturated fatty acids metabolism and immune activation.

Hypertension-associated gut dysbiosis drives target organ damage through impaired polyunsaturated fatty acids metabolism and immune activation.

Journal: Pharmacological research
Published: March 23, 2026
Showing 1-12 of 624

Last Updated: 09/26/2026